A drug that inhibits the molecule known as prostaglandin E2 (PGE2) increased survival rates in mice infected with a lethal dose of the H1N1 flu virus.
Researchers have sequenced the entire genome and all the RNA products of the most important pathogenic lineage of Cryptococcus neoformans, a strain called H99 — a fungus responsible for a million cases of pneumonia and meningitis every year.
The USGS and CDC have found antibodies for the 2009 H1N1 flu virus in blood samples from 70% of the sea otters studied
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the most common cause of admission in children under the age of 1.
A 3-D laboratory method has been developed to test asthma and allergy medications that could reduce the need to test the drugs on animals.
Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute (TGen).
A rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections, according to a National Institutes of Health (NIH) study published in The New England Journal of Medicine.
A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance,
Moderate to severe obstructive sleep apnea is independently associated with an increased risk of stroke, cancer and death, according to study results published in the Journal of Clinical Sleep Medicine.
The drug sirolimus slows progression of a severe and progressive lung disease called lymphangioleiomyomatosis (LAM), but the drug can cause fatal complications for those patients needing lung transplant.